Effect Of Sodium Benzoate Research Articles

Effect of Sodium Benzoate as an Add-on Therapy on the Clinical and Cognitive Symptoms of Schizophrenia: A Case Series

Effect of Sodium Benzoate as an Add-on Therapy on the Clinical and Cognitive Symptoms of Schizophrenia: A Case Series

The Effect of Sodium Benzoate on Host Health: Insight into Physiological Indexes and Gut Microbiota.

Sodium benzoate (SB) is a common food preservative widely used in the food industry. However, the effects of SB intake on host health at different stages were still unclear. Hence, we investigated the impact of SB with three concentrations (150 mg/kg, 500 mg/kg and 1000 mg/kg) and at three stages (intake for 5-weeks, intake for 10-weeks and removal for 5 weeks) on host health in normal mice. The results showed that SB intake for 5 weeks slightly changed gut microbiota composition, but it significantly increased TG (only 150 mg/kg and 1000 mg/kg) and blood glucose levels (only 500 mg/kg) and promoted the secretion of interleukin (IL)-1β and IL-6 (p < 0.01). However, SB intake for 10 weeks mostly maintained normal glucolipid metabolism; although, IL-1β (p < 0.01) and IL-6 (p < 0.05) levels were also significantly increased and positively regulated the gut microbiota by significantly increasing the relative abundance of Lactobacillus and significantly decreasing the relative abundance of Ileibacterium. Meanwhile, the safety of SB for host metabolism and gut microbiota was also confirmed via a fecal microbiota transplantation experiment. In addition, we found that SB removal after 10 weeks of intake significantly increased the levels of blood glucose, insulin and HOMA-IR index, which might be attributed to gut microbiota dysbiosis. Mechanistically, these positive effects and negative effects had no close relationship with the concentration of short-chain fatty acids in the gut, which might be associated with metabolites of SB or special bacterial strains. In short, this work provided positive evidence for the safety of SB consumption within the recommended range.

Effects of Sodium Benzoate Application, Silage Relocation, and Storage Time on the Preservation Quality of Sugarcane Silage

The present study explored the effects of sodium benzoate (SB), relocation, and storage time on the quality of sugarcane silage. The experiments followed a completely randomized design with a 2 × 4 × 2 factorial arrangement and four replicates. The treatments were as follows: (i) with (SB+) or without (SB−) SB (2 g∙kg−1 on a fresh matter basis); (ii) with (R) or without (R0) relocation for 12, 48, and 72 h (R12, R48, and R72, respectively); and (iii) storage for 10 or 60 days after relocation. SB− silage showed a lower (p &lt; 0.05) dry matter loss (DML = 155 g·kg−1) without relocation (R0). SB+ silage showed the highest (p &lt; 0.05) DML (257 g·kg−1) with R72. SB use reduced (p &lt; 0.05) the yeast count in silage that was stored for 10 days (SB+: 4.63 CFU·g−1; SB−: 5.58 CFU·g−1). The yeast count was higher (p &lt; 0.05) in silage that was stored for 10 days after relocation, regardless of the relocation time. SB use increased the aerobic stability of silage after 10 days of storage. Thus, SB application is effective for the inhibition of yeast in relocated sugarcane silage. We recommend the use of SB when silage is relocated for 12 h and stored for 60 days after relocation.

Screening the immunotoxicity of different food preservative agents on the model organism Galleria mellonella L. (Lepidoptera: Pyralidae) larvae

Immunotoxic effects of sodium benzoate (SB, E211), sodium nitrate (SNa, E251), and sodium nitrite (SNi, E250), a few of the most common food preservatives, on the model organism Galleria mellonella L. (Lepidoptera: Pyralidae) larvae were investigated in this study. The last instar larvae were used for all experimental analyses. For this purpose, median lethal doses of SB, SNa, and SNi were applied to the larvae by the force-feeding method. We found that force-feeding G. mellonella larvae with SB, SNa, and SNi significantly reduced the larval total hemocyte counts, prohemocyte, and granulocyte ratios but increased plasmatocyte, spherulocyte, and oenocyte ratios, as well as the hemocyte mitotic indices and micronucleus frequency. The spreading ability of hemocytes and hemocyte-mediated immune responses were lower in the SB, SNa-, and SNi-treated larval groups compared to controls. Apoptotic indices were higher in all larval groups treated with food preservatives, but increments in necrotic indices were only significantly higher in SNi-treated larvae compared to controls. Our research shows that SB, SNa, and SNi have immunotoxic and cytotoxic potential on G. mellonella larvae. Thus, we suggest that G. mellonella larvae can be used as preliminary in vivo models to screen the immunotoxic effects of food preservative agents.

Effect of sodium benzoate on some biochemical, physiological and histopathological aspects in adult male rats

Sodium benzoate SB is a white powder, used as preservative and food additive. Biochemical, physiological and histopathological effects of SB been tested in adult male rats. Twenty-four adult albino male rats aged100 day and weighted 250-350 g were used. Animals were divided into 4 groups. The first group considered as control, which received normal saline orally, other groups treated with SB by 300, 400, 500 mg/Kg of body weight respectively for 30 days. At the end of experiment, blood samples were collected from retro orbital sinus. Heart, liver, spleen, kidneys and brain were obtained for weight recording. The results indicated a significant decrease of super oxide dismutase SOD activity and a significant increase of nitric oxide NO level of treated group 500 mg/Kg of body weight. Moreover, findings revealed that there are no significant changes in growth hormone GH activity and body weight. A significant reduction of heart weight of treated group 500 mg/Kg of body weight were observed. The histopathological changes ranged from mild to severe in the brain cortex, as focal gliosis, satellitosis, mild vacuolation and vasogenic edema in treated groups with SB by different doses. Also, some changes were observed in liver represented by congestion of portal vein, mild hydropic degeneration of hepatocytes, stenosis of sinusoids, steatosis and necrosis of hepatocytes in treated groups with SB compared to control group. It concluded that short-term exposure to high doses of SB may be considered an oxidant substance that caused oxidative stress. Furthermore, SB can harm various organs in the body.

Evaluation of the antibacterial and antibiofilm activities of sodium benzoate against the soft rot disease of tomato in Iraq

Pectobacterium carotovorum is one of the most serious pectolytic bacterial pathogens causing significant pre- and postharvest soft rot diseases on a variety of agroeconomic fruits and vegetables worldwide. Application of chemical pesticides for controlling the postharvest diseases is still insufficient and unacceptable by consumers. The effect of sodium benzoate (C6H5COONa) (SBN) was evaluated against the growth of P. carotovorum utilizing the highly pathogenic strain BR03, confirmed molecularly using dnaA primers. The inhibition zone was the greatest when P. carotovorum was treated with 600 mM SBN both at pH 7.5 and 7.0. Flow cytometry (distinguishing live and dead bacterial cells) and the development of bacterial colonies on Petri plates confirmed the bactericidal action of SBN. In addition, these results validated that bacterial cells were killed when treated with 600 mM SBN. The biofilm formation was completely inhibited and destroyed following exposure to 600 mM SBN after a 24-h incubation period and the absorbance readings were reduced as the concentration of SBN increased. Disease severity on inoculated tomato fruits decreased in comparison with the control fruit at either 4 or 25 °C. SBN is safe for human health and commonly used in industries as a food preservative. SBN can be an effective alternative method for controlling soft rot diseases on tomato fruits.

Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial.

BackgroundCompared with adults with depression in the general population, elderly depressive patients are prone to poor treatment response, more side effects, and early withdrawal with current antidepressants (which principally modulate monoamines). Whether N-methyl-D-aspartate receptor enhancement can benefit treatment of late-life depression deserves study. This study aims to compare sodium benzoate (a D-amino acid oxidase inhibitor and an indirect N-methyl-D-aspartate receptor enhancer), sertraline (a selective serotonin reuptake inhibitor), and placebo in the treatment of late-life depression.MethodsIn this randomized, double-blind trial, 117 patients with major depressive disorder aged 55 years or older received 8-week treatment of 250–1500 mg/d of sodium benzoate, 25–150 mg/d of sertraline, or placebo in 2 medical centers. The primary outcome measures were Hamilton Depression Rating Scale and Perceived Stress Scale scores.ResultsThree treatments similarly decreased clinicians-rated Hamilton Depression Rating Scale scores. Compared with placebo, sodium benzoate but not sertraline substantially improved Perceived Stress Scale scores and cognitive function. Sertraline, but not benzoate, significantly reduced self-report Geriatric Depression Scale scores. Benzoate and placebo showed similar safety profiles, while sertraline was more likely to raise low-density lipoprotein than benzoate and placebo. Benzoate-treated patients were less likely to drop out than sertraline or placebo recipients.ConclusionsSertraline can reduce subjective depressive symptoms, while benzoate can decrease perceived stress, improve cognitive function, and enhance treatment adherence in late-life depression patients. The results show promise for D-amino acid oxidase inhibition as a novel approach for perceived stress and cognitive decline among patients with late-life depression.Trial RegistrationClinicalTrials.gov Identifier: NCT03414931. Registered January 2016.

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia

Female gender is a major risk factor for dementia; however, gender has not yet been adequately addressed by clinical trials. A recent study demonstrated that sodium benzoate, a D-amino acid oxidase inhibitor, improved cognitive function in early-phase Alzheimer disease. To examine the potential gender difference in the effects of benzoate treatment on the behavioral and psychological symptoms of dementia (BPSD). This post hoc secondary analysis used data from a randomized, double-masked, placebo-controlled trial conducted in 3 major medical centers in Taiwan and enrolled 97 patients with BPSD. Data were analyzed between February 2014 and November 2017. Six weeks of treatment of 250 to 1500 mg/d of sodium benzoate or placebo. The primary outcome measures were Alzheimer disease assessment scale-cognitive subscale (ADAS-cog) and Behavioral Pathology in Alzheimer Disease Rating Scale (BEHAVE-AD) scores. Among 97 total participants (62 [64%] women; mean [SD] age, 75.4 [7.7] years), 49 patients (30 women and 19 men) were randomized to sodium benzoate, and 48 (32 women and 16 men) were randomized to placebo. Among 62 women, 6-week benzoate treatment significantly surpassed placebo in the effects on ADAS-cog performance (mean [SD] difference in score between baseline and end point, -3.1 [6.4] points vs 0 [4.5] points; Cohen d = 0.56; P = .04) but not BEHAVE-AD performance. In contrast, among 35 men, the 2 treatment groups did not differ significantly in both ADAS-cog and BEHAVE-AD scores. Compared with placebo, benzoate treatment also increased estradiol to follicle-stimulating hormone ratios among women (mean [SD] difference between baseline and end point, 0 [0.2] vs -0.1 [0.3]; P = .03). These findings suggest that benzoate treatment may improve cognitive function in women with later-phase dementia. In the future, longer dose-finding trials are warranted to further clarify the efficacy of benzoate for later-phase dementia and investigate the role of sex hormones and other factors in the pathogenesis of dementia. ClinicalTrials.gov Identifier: NCT02103673.

Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis

There is evidence that sodium benzoate (BZ) may be an effective adjunctive treatment for schizophrenia. The clinical efficacy of BZ has been investigated in chronic schizophrenia; however, the efficacy of this agent has not been studied in individuals with early psychosis. To examine the clinical efficacy of the adjunctive use of BZ for symptoms in people with early psychosis. Using a placebo-controlled double-masked parallel-group design, this randomized clinical trial was conducted from August 2015 to July 2018. Participants aged between 15 and 45 years experiencing early psychosis were enrolled from 5 major clinical sites in Queensland, Australia. Data analysis was conducted from October 2018 to February 2020. Participants were randomized 1:1 (50 participants in each group) to receive 500 mg of sodium benzoate twice daily or placebo for 12 weeks. The primary efficacy outcome was the Positive and Negative Syndrome Scale (PANSS) total score at 12 weeks. The key secondary efficacy measures were (1) the Clinical Global Impression score, (2) the Hamilton Depression Rating Scale for depression, (3) functioning as assessed by the clinician-rated Global Assessment of Function, and (4) the Assessment of Quality of Life Scale. The PANSS subscale scores and impact on selected amino acid concentrations were also assessed. The study comprised 100 participants with a mean (SD) age of 21.4 (4.1) years, of whom 73 (73%) were male individuals. The mean (SD) baseline PANSS score was 75.3 (15.4). We found no improvement in total PANSS score in the BZ group compared with the placebo group. The end result of least-squares mean difference (SE) for total PANSS was -1.2 (2.4) (P = .63). There were no differences in any subscales of the PANSS, any secondary measures, nor any amino acid concentrations. The dose of BZ was well tolerated without any clinically significant treatment-emergent adverse event differences between BZ and placebo groups. In this randomized clinical trial, there was no evidence that adjunctive use of 500 mg of BZ twice daily is an effective treatment for individuals with early psychosis. anzctr.org.au Identifier: ACTRN12615000187549.

Inhibitory effect of Sodium Benzoate as Preservative Material in the Biogas Production in a Batch Anaerobic Digestion Process

Inhibitory effect of Sodium Benzoate as Preservative Material in the Biogas Production in a Batch Anaerobic Digestion Process

The effects of sodium benzoate on structure of the proximal growth plate of the humerus and the thyroid gland

The effects of sodium benzoate on structure of the proximal growth plate of the humerus and the thyroid gland

Effect of sodium benzoate and chlorhexidine gluconate on a bio-thermoplastic elastomer made from thermoplastic starch-chitosan blended with epoxidized natural rubber

Thermoplastic elastomer (TPE) was developed by blending thermoplastic starch (TPS) with rubber. Thermoplastic starch-chitosan (TPSC) was prepared by the solution mixing of cassava starch, chitosan (CTS) and glycerol in acidified water (lactic acid 1 wt%) at 80 °C follow by melt mixing at 130 °C. Sodium benzoate (BEN) and chlorhexidine gluconate (Cl) were added during the solution mixing as additives for antimicrobial properties. TPSC was melt-mixed with epoxidized natural rubber (ENR) (70/30 wt/wt). The tensile strength and elongation at break of the TPSC/ENR increased with the additive content. Elastic recovery was improved by the addition of Cl. A new peak in the FTIR data confirmed the reaction between the reactive functional groups of the CTS and the additives with the epoxy groups of ENR. These reactions and miscibility of the TPSC/ENR/additives blends improved the mechanical properties, elasticity, morphology, and antimicrobial properties of the blends.

Effects of sodium benzoate on growth and physiological characteristics of wheat seedlings under compound heavy metal stress

In this study, we investigated the effect of exogenous sodium benzoate on wheat seedlings (Yangmai 16) grown under heavy metal stress. The results showed that 2.4 mmol kg−1 of heavy metals significantly inhibited growth and delayed emergence of wheat seedlings. Under compound heavy metal stress, application of 2–4 g L−1 sodium benzoate significantly increased (P>0.01) chlorophyll content and chlorophyll fluorescence parameters Fv/Fm and Fv/Fo of wheat, compared to the control (water treatment). Further analysis showed that application of 2–4 g L−1 sodium benzoate alleviated osmotic stress by promoting the accumulation of osmolytes such as soluble proteins and free proline, increased the activity of superoxide dismutase (SOD) and reduced malondialdehyde content (MDA). In contrast, higher concentrations of sodium benzoate solution (>6 g L−1) inhibited the growth of wheat seedlings and even caused damage to seedlings. Correlation analysis showed that when the sodium benzoate concentration was in the range of 1.97–3.12 g L−1 (2016) and 1.58–3.27 g L−1 (2017), values of chlorophyll and its components, root activity, SOD activity, soluble protein, and free proline content were the highest. When the sodium benzoate concentration was raised to 2.59 g L−1 (2016) or 3.02 g L−1 (2017), MDA content was the lowest. Ultimately, exogenous sodium benzoate (2–4 g L−1) facilitates root development and improves the root activity of wheat seedlings grown under compound heavy metals stress, thereby effectively alleviating the damage of compound heavy metal stress in wheat seedlings.

Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood-A Double-blind Randomized Controlled Trial.

The objective was to evaluate the efficacy and safety of sodium benzoate in the management of hyperammonemia and hepatic encephalopathy (HE) in decompensated chronic liver disease. It was a prospective, interventional, double-blinded randomized controlled trial conducted from August 2017 to December 2018. Children with decompensated chronic liver disease and hyperammonemia were included in the study. Those with ammonia >400 μg/dL, already receiving sodium benzoate or with grade III ascites were excluded. Group A received sodium benzoate (400 mg/kg loading dose followed by 200 mg · kg · daymaintenance for 5 days) along with the standard medical therapy. Group B received standard medical therapy with placebo. A total of 108 episodes of hyperammonemia occurred in 86 patients of whom 16 were excluded. The final analysis included 46 episodes in each group. The median decrease in ammonia from baseline to day 5 was 52 μg/dL in group A versus 42 μg/dL in group B (P = 0.321). There was a significant decrease in ammonia on days 1 and 2 in group A as compared to group B, but not on subsequent days. There was no significant difference in the resolution of HE (57.1% vs 50%; P = 1), but there was higher, albeit insignificant increase in ascites in group A (15.9% vs 4.5%). Addition of sodium benzoate significantly reduced the ammonia levels on the first 2 days of therapy but the effect was not sustained till day 5. The effect of sodium benzoate would probably be more sustained, if higher dosage (400 mg · kg · day) could be used under monitoring of benzoate levels. There was no effect on resolution of HE. Sodium benzoate caused an increasing trend of adverse events with no effect on short-term survival.

Effect of Sodium Benzoate on Reducing Inflammatory Symptoms in Animal Models of Rheumatoid Arthritis

Effect of Sodium Benzoate on Reducing Inflammatory Symptoms in Animal Models of Rheumatoid Arthritis

Chemical composition and antibacterial effects of some essential oils individually and in combination with sodium benzoate against methicillin-resistant Staphylococcus aureus and Yersinia enterocolitica.

Side effects of chemical preservatives and drug resistance have raised interest in use of herbal products. This study aimed to examine the chemical composition and antibacterial effects of Cuminum cyminum, Mentha spicata, and Mentha longifolia essential oils individually and in combination with sodium benzoate against methicillin-resistant Staphylococcus aureus and Yersinia enterocolitica. The essential oils were analyzed by gas chromatography-mass spectrometry. Disc diffusion and microdilution assays were used for in vitro antimicrobial screening. The main components were cumin aldehyde, carvone, and pulegone in C. cyminum, M. spicata, and M. longifolia essential oils, respectively. Antibacterial data analysis showed significant differences between different antibacterial effects of essential oils individually and in combination with sodium benzoate. In terms of individual effects, antibacterial effect of M. longifolia and C. cyminum essential oils were the highest against methicillin-resistant S. aureus and Y. enterocolitica, respectively. The antibacterial effects of sodium benzoate combined with essential oils showed significant differences with the individual effect of sodium benzoate in most cases. The results indicated that the combined effect of these essential oils with sodium benzoate could reduce the use of sodium benzoate as an antimicrobial agent, which could decrease its possible side effects. Thus, for more significant effects, these essential oils could be combined with other agents for the preservation of drug and food products.

The effect of sodium benzoate on the nutritive value of rehydrated sorghum grain silage for dairy cows

The objective of this trial was to evaluate the nutritional value of rehydrated sorghum grain silage treated with sodium benzoate, for use in dairy cow feed. Fifteen-hundred kg of dry ground sorghum were rehydrated to 350 g/kg moisture and ensiled in 200-L plastic drums. At ensiling, grain was either treated with sodium benzoate at 2 g/kg as fed (Benzoate) or nothing (Control). Twelve mid-lactating Holstein cows, with 170 ± 47 d in milk, received a standard diet for 14 d, and then were paired blocked and assigned to one of two dietary treatments for 28 d. Diets contained (dry matter basis): 360 g/kg corn silage, 48 g/kg Tifton haylage, 122 g/kg whole cottonseed, 184 g/kg soybean meal, 27 g/kg mineral-vitamin premix, and 258 g/kg rehydrated sorghum grain silage (Control or Benzoate). Dry matter intake, milk yield and composition were measured weekly, whereas rumen fermentation profile and feeding behavior were measured the last week of the experimental period. Silages treated with sodium benzoate had lower concentrations of ethanol (P = 0.05), ethyl-esters (P < 0.05) and soluble protein (P =0.02), and less yeast counts (P < 0.01). Therefore, silage treated with benzoate had higher aerobic stability compared to control silages (P < 0.01). Ruminal acetate to propionate ratio was lower in cows fed the control treatment compared to benzoate (2.66 vs. 2.96), due to the greater proportion of propionate in the rumen fluid (19.0 vs. 17.8 mol/100 mol of volatile fatty acids). However, dry matter intake, milk yield and composition did not differ between treatments. Sodium benzoate changed silo and rumen fermentation profile without altering the performance of mid-lactation dairy cows.

Effect of sodium benzoate on liver and kidney lipid peroxidation and antioxidant enzymes in mice

Introduction: Sodium benzoate (SB), as a chemical preservative, is used in many kinds of foodstuff. Some studies reported toxicity effects of SB in food products and suggested to limit its usage. The aim of this study was to evaluate the effects of oral administration of SB on antioxidant enzymes and lipid peroxidation in the liver and kidney of mice. Materials and Methods: A total of 24 animals were divided into four groups: Control group and three treated groups that received 150, 300, and 600 mg/kg/day of SB, respectively, in drinking water for 4 weeks. The malondialdehyde level, glutathione (GSH) content, superoxide dismutase (SOD), and catalase (CAT) activities of the liver and kidney were measured and the results of the treated groups were compared with those of the control group (one-way analysis of variance). Results: Results showed that SB caused histological alterations in the liver and kidney tissues. Moreover, SB significantly increased lipid peroxidation and GSH content in the kidney tissues (P < 0.05). Also, CAT activity significantly declined in the kidney (P < 0.05), without changing the SOD activity, but SB did not have any effect on the biochemical parameter of the liver tissue. Conclusion: The results of this study showed that SB caused kidney injury more than liver injury, but as a food preservative, which is consumed for a long period of life, it may cause liver damage additionally. For that reason, the excessive SB intake in the food is disturbing.

Effect of Sodium Benzoate on Corticosterone Hormone Level, Oxidative Stress Indicators and Electrolytes in Immature Male Rats

Effect of Sodium Benzoate on Corticosterone Hormone Level, Oxidative Stress Indicators and Electrolytes in Immature Male Rats

Toxic Effects of Sodium Benzoate on the Rat Testes

Toxic Effects of Sodium Benzoate on the Rat Testes